...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith share issue
5
Nov 13, 2017 11:10PM
2
Nov 14, 2017 12:34PM
7
Nov 14, 2017 12:47PM

would love to see a major deal with a BP but we have never had one to this point,  It would hugely legitimize the science of Zenith and RVX and would be a good catalyst for share movement for RVX   (IMO)  

3
Nov 15, 2017 11:07AM
6
Nov 15, 2017 12:39PM
6
Nov 15, 2017 02:41PM
6
Nov 15, 2017 03:30PM
Share
New Message
Please login to post a reply